Infectious Disease In-vitro Diagnostic Market

The global Infectious Disease In-vitro Diagnostic market was valued at US$ 58 million in 2022 and is projected to reach US$ 75 million by 2029, at a CAGR of 3.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Infectious Disease In-vitro Diagnostic Market aims to provide a comprehensive presentation of the global market for Infectious Disease In-vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In-vitro Diagnostic. Infectious Disease In-vitro Diagnostic Market contains market size and forecasts of Infectious Disease In-vitro Diagnostic in global, including the following market information:

• Global Infectious Disease In-vitro Diagnostic Market Revenue, 2018-2023, 2024-2032, ($ millions)
• Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunoassay Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease In-vitro Diagnostic include BD, BioM?rieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Disease In-vitro Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease In-vitro Diagnostic Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Infectious Disease In-vitro Diagnostic Market Segment Percentages, by Type, 2022 (%)

• Immunoassay
• Molecular Diagnostics
• Microbiology
• Others

Global Infectious Disease In-vitro Diagnostic Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Infectious Disease In-vitro Diagnostic Market Segment Percentages, by Application, 2022 (%)

• COVID-19
• MRSA
• Clostridium Difficile
• Respiratory Virus
• TB and Drug-resistant TB
• Chlamydia
• Gonorrhea
• HPV
• HIV

Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
Global Infectious Disease In-vitro Diagnostic Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Infectious Disease In-vitro Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease In-vitro Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infectious Disease In-vitro Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• BD
• BioM?rieux SA
• Abbott
• Quidel Corporation
• OraSure Technologies, Inc.
• Hologic, Inc. (Gen Probe)
• Danaher
• QIAGEN
• Roche
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Infectious Disease In-vitro Diagnostic, market overview.
• Chapter 2: Global Infectious Disease In-vitro Diagnostic market size in revenue.
• Chapter 3: Detailed analysis of Infectious Disease In-vitro Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Infectious Disease In-vitro Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy